USA Pickleball Names DePuy Synthes as Official Orthopaedics Sponsor

USA Pickleball, the National Governing Body for the sport of pickleball in the United States, today announced DePuy Synthes, a global leader in orthopaedic technologies and solutions, as an Official Orthopaedics Sponsor of USA Pickleball, with an exclusive focus on Early Intervention Orthopaedic Treatments. Through the sponsorship, players and fans will connect with educational resources surrounding joint health and early intervention treatment options, including MONOVISC® (High Molecular Weight Hyaluronan), a single-injection treatment for osteoarthritis knee pain. As pickleball continues to attract players across a wide range of ages and skill levels, the partnership reflects USA Pickleball's commitment to providing its community with access to information and resources that can help support an active lifestyle and keep players engaged in the sport they love.

"Supporting our community means connecting players with resources that can help them stay active and on the court," said Christian Portaro, Vice President of Partnerships at USA Pickleball. "We're excited to welcome DePuy Synthes as an Official Orthopaedics Sponsor and work together to bring valuable education around joint health and early intervention treatment options to pickleball players nationwide."

The sponsorship will come to life for the first time at the 2026 Oceanview USA Pickleball National Championships, taking place Oct. 31–Nov. 8 at Barnes Tennis Center in San Diego. DePuy Synthes will engage with players and spectators throughout the event, providing opportunities to learn more about MONOVISC®, whether it may be an appropriate treatment option for osteoarthritis knee pain, and resources to help individuals find a healthcare provider. About MONOVISC® (High Molecular Weight Hyaluronan) MONOVISC should not be taken if you are allergic to hyaluronate products. If you have any known allergies, you should consult with your healthcare professional. You should not have an injection into the knee if you have infections or skin diseases around the injection site. Possible side effects of MONOVISC injections in the knee joint: pain, swelling, heat, rash, itching, bruising and/or redness. You may also feel achy. These reactions are generally mild and do not last long. If any of these symptoms or signs appear after you are given MONOVISC or if you have any other problems, you should call your healthcare professional. Things you should know about MONOVISC: These products should be injected by a qualified physician or properly licensed practitioner. Tell your healthcare professional if you have any known allergies before MONOVISC is administered. For 48 hours after you receive the injection, you should avoid activities such as jogging, tennis, heavy lifting or standing on your feet for a long time (more than one hour). The safety and effectiveness of MONOVISC in joints other than the knee has not been demonstrated in U.S. studies. The safety and effectiveness of MONOVISC has not been shown in pregnant or nursing women. You should tell your healthcare professional if you are pregnant or nursing. The safety and effectiveness of MONOVISC has not been shown in children. The effectiveness of repeat treatment with MONOVISC has not been studied. However, the safety profile of a one-time re-treatment with MONOVISC was demonstrated to be similar to the initial treatment.